ArticleDermatology and therapy2026

Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.

Eingun James Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.